Abstract
Two-dimensional gel electrophoresis is a standard tool of proteomic analysis, consisting of first dimensional protein separation according to the respective proteins isoelectric point, and the second dimensional separation according to the proteins molecular weight. In these gels, “chain-like” protein spots of equal molecular weight but different isoelectric points are common observations. When identified by mass spectrometry, these chain-like protein spots are identified as the same protein entry in the databases, thus representing “protein species” in the proteomic literature. In this review, we will discuss the factors responsible for the occurrence of multiple protein species, which mostly depend on posttranslational modifications (PTMs) such as phosphorylation and glycosylation and others. Additionally, we will show how internet-based prediction tools can be used for comparing the theoretical models to the actual gel pattern. This may present useful tools for the validation of biomarkers in health and disease.
Keywords: Isoelectric point, proteomics, protein species shift, post-translational modification, two-dimensional gel electrophoresis, phosphorylation, glycosylation, biomarkers, liquid chromatography, isoelectric focusing
Current Proteomics
Title: Web-Based Tools for the Interpretation of Chain-Like Protein Spot Patterns on Two-Dimensional Gels
Volume: 9 Issue: 1
Author(s): Martin H. Maurer
Affiliation:
Keywords: Isoelectric point, proteomics, protein species shift, post-translational modification, two-dimensional gel electrophoresis, phosphorylation, glycosylation, biomarkers, liquid chromatography, isoelectric focusing
Abstract: Two-dimensional gel electrophoresis is a standard tool of proteomic analysis, consisting of first dimensional protein separation according to the respective proteins isoelectric point, and the second dimensional separation according to the proteins molecular weight. In these gels, “chain-like” protein spots of equal molecular weight but different isoelectric points are common observations. When identified by mass spectrometry, these chain-like protein spots are identified as the same protein entry in the databases, thus representing “protein species” in the proteomic literature. In this review, we will discuss the factors responsible for the occurrence of multiple protein species, which mostly depend on posttranslational modifications (PTMs) such as phosphorylation and glycosylation and others. Additionally, we will show how internet-based prediction tools can be used for comparing the theoretical models to the actual gel pattern. This may present useful tools for the validation of biomarkers in health and disease.
Export Options
About this article
Cite this article as:
H. Maurer Martin, Web-Based Tools for the Interpretation of Chain-Like Protein Spot Patterns on Two-Dimensional Gels, Current Proteomics 2012; 9 (1) . https://dx.doi.org/10.2174/157016412799746236
DOI https://dx.doi.org/10.2174/157016412799746236 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ethnomedicinal Plants for the Management of Diabetes Worldwide: A Systematic Review
Current Medicinal Chemistry Initiation of Dialysis: A Mini-Review of a Changing Paradigm
Cardiovascular & Hematological Disorders-Drug Targets Computer-Based versus Paper-Based Insulin Infusion Algorithms in Diabetic Ketoacidosis
Current Diabetes Reviews The Role of Calcium and the L-Type Calcium Channel in Pathological Remodeling of the Heart
Vascular Disease Prevention (Discontinued) Therapeutic Interventions in the Glyc(oxid)ation Pathway
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Indiana Alzheimer Disease Centers Symposium on Mild Cognitive Impairment. Cognitive Training in Older Adults: Lessons from the ACTIVE Study
Current Alzheimer Research Anti-Inflammatory Effects of C-Peptide Prevent Endothelial Dysfunction in Type 1 Diabetes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Vasoactive Role of Nitric Oxide: Physiological and Morphological Aspects
Current Pharmaceutical Biotechnology Update Clinical Application of Diffusion Tensor Imaging
Current Medical Imaging Methodological Aspects of Phytosterol Measurements in Biological Samples
Current Medicinal Chemistry Potassium Channels and Uterine Vascular Adaptation to Pregnancy and Chronic Hypoxia
Current Vascular Pharmacology Biocatalysis: Synthesis of Chiral Intermediates for Pharmaceuticals
Current Organic Chemistry Mitochondrial Effects of Organoselenium and Organotellurium Compounds
Current Organic Chemistry Detection of Obstructive Sleep Apnea Using Internet of Things: A Review
International Journal of Sensors, Wireless Communications and Control Effect of Colestimide on Reduction of Body Weight and Waist Circumference in Metabolic Syndrome Patients with Cardiovascular Risk Factors
Vascular Disease Prevention (Discontinued) Role of Calabrian Black Rice in Metabolic Syndrome: In vitro Evaluation of Oryza sativa L. Indica Biological Properties
Current Nutrition & Food Science Follow-Up Study of Olfactory Deficits, Cognitive Functions, and Volume Loss of Medial Temporal Lobe Structures in Patients with Mild Cognitive Impairment
Current Alzheimer Research “Virostatics” as a Potential New Class of HIV Drugs
Current Pharmaceutical Design Polyamines in the Brain: Distribution, Biological Interactions, and their Potential Therapeutic Role in Brain Ischaemia
Current Medicinal Chemistry Editorial [Hot Topic: New Developments in Therapy for Oxidative Stress-Related Diseases: Pathophysiological and Clinical Consequences (Executive Guest Editor: Victor M. Victor)]
Current Pharmaceutical Design